ARTICLE | Distillery Therapeutics
Cancer
November 30, 2016 2:19 PM UTC
In vitro, cell culture and mouse studies identified a tetrahydroimidazoazepinol-based CSN5 inhibitor that could help treat anaplastic large cell lymphoma (ALCL) and other cancers. Screening of a small...
BCIQ Company Profiles
BCIQ Target Profiles